| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |